{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:44:54Z","timestamp":1780418694404,"version":"3.54.1"},"reference-count":28,"publisher":"National Institute of Industrial Health","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ind Health"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2486\/indhealth.45.497","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T05:48:43Z","timestamp":1184305723000},"page":"497-500","source":"Crossref","is-referenced-by-count":21,"title":["Dopamine Transporter SPECT of a Liver Cirrhotic with Atypical Parkinsonism"],"prefix":"10.2486","volume":"45","author":[{"given":"Jongchul","family":"KIM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Kyeong","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Woo","family":"SHIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hoon","family":"CHOI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Eun","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangho","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tarter R, Hays A, Sandford S, van Thiel D (1986) Cerebral morphological abnormalities associated with non-alcoholic cirrhosis. Lancet 2, 893-5.","DOI":"10.1016\/S0140-6736(86)90413-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hanner J, Li K, Davis G (1988) Acquired hepatocerebral degeneration: MR similarity with Wilson disease. J Comput Assisted Tomogr 12, 1076-7.","DOI":"10.1097\/00004728-198811000-00036"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Moore J, Dunk A, Crawford J, Deans H, Besson JA, De Lacey G, Sinclair TS, Mowat NA, Brunt PW (1989) Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis: a controlled study. J Hepatol 9, 319-25.","DOI":"10.1016\/0168-8278(89)90140-2"},{"key":"4","unstructured":"4) Kulisevsky J, Ruscadella J, Grau J (1991) MR imaging of acquired hepatocerebral degeneration. Am J Neuroradiol 12, 527-8."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zeneroli M, Cioni G, Crisi G, Vezzelli C, Ventura E (1991) Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: a MR imaging study. Magn Reson Imaging 9, 295-302.","DOI":"10.1016\/0730-725X(91)90414-H"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360611"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Awada A, Sullivan S, Palkar V, Sbeih F, Naufal R, Al Rajeh S (1995) Brain magnetic resonance imaging in non-alcoholic cirrhosis. Eur J Radiol 21, 84-8.","DOI":"10.1016\/0720-048X(95)00694-L"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Butterworth R, Spahr L, Fontaine S, Pomier-Layrargues G (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10, 259-67.","DOI":"10.1007\/BF02109357"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jog M, Lang A (1995) Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 10, 714-22.","DOI":"10.1002\/mds.870100604"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92164-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D (1996) Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images (MRIs) in liver cirrhosis. Gastroenterology 111, 147-55.","DOI":"10.1053\/gast.1996.v111.pm8698193"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1996.v24.pm0008903385"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80290-5"},{"key":"14","unstructured":"14) Lee J, Lacomis D, Cornu S, Jacobsohn J, Kanal E (1998) Acquired hepatocerebral degeneration: MR and pathologic findings. Am J Neuroradiol 19, 485-7."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Weissenborn K, Kolbe H (1998) The basal ganglia and portal-systemic encephalopathy. Metab Brain Dis 13, 261-72.","DOI":"10.1023\/A:1020628607245"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Spahr L, Vingerhoets F, Lazeyras F, Delavelle J, DuPasquier R, Giostra E, Mentha G, Terrier F, Hadengue A (2000) Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 119, 774-81.","DOI":"10.1053\/gast.2000.17857"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Burkhard PR, Delavelle J, Du Pasquier R, Spahr L (2003) Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60, 521-8.","DOI":"10.1001\/archneur.60.4.521"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N (2005) Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol 62, 1385-90.","DOI":"10.1001\/archneur.62.9.1385"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, Kotagal V, Perlmutter JS (2005) [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov Disord 20, 492-6.","DOI":"10.1002\/mds.20381"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44, 1583-6.","DOI":"10.1212\/WNL.44.9.1583"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pomier-Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345, 735.","DOI":"10.1016\/S0140-6736(95)90909-5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Layrargues GP, Shapcott D, Spahr L, Butterworth RF (1995) Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 10, 353-6.","DOI":"10.1007\/BF02109365"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Huang CC,Weng YH, Lu CS, Chu NS, Yen TC (2003) Dopamine transporter binding in chronic manganese intoxication. J Neurol 250, 1335-9.","DOI":"10.1007\/s00415-003-0214-1"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Huang CC, Lu CS, Chu NS, Hochberg F, Lilienfeld D, Olanow W, Calne DB (1993) Progression after chronic manganese exposure. Neurology 43, 1479-83.","DOI":"10.1212\/WNL.43.8.1479"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57, 1497-9.","DOI":"10.1212\/WNL.57.8.1497"},{"key":"26","unstructured":"26) Gibb WRG (1993) The neuropathology of parkinsonian disorders. In: Parkinson's disease and movement disorders. Jankovic J and Tolosa E (Eds.), 253-70, Williams and Wilkins, Baltimore."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kim Y (2006) Neuroimaging in manganism. Neurotoxicology 27, 369-72.","DOI":"10.1016\/j.neuro.2005.12.002"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Devenyi AG, Barron RF, Mamourian AC (1994) Dystonia, hyperintense basal ganglia and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 106, 1068-71.","DOI":"10.1016\/0016-5085(94)90769-2"}],"container-title":["Industrial Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/indhealth\/45\/3\/45_3_497\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T15:26:54Z","timestamp":1621524414000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/indhealth\/45\/3\/45_3_497\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.2486\/indhealth.45.497","relation":{},"ISSN":["0019-8366","1880-8026"],"issn-type":[{"value":"0019-8366","type":"print"},{"value":"1880-8026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}